
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $742K | -- | -- | -$0.01 | -- |
08/08/2025 | Q2 | $1.1M | -- | -- | $0.03 | -- |
05/12/2025 | Q1 | $654K | $692K | -$0.02 | -$0.02 | -- |
03/26/2025 | Q4 | -- | $422K | -$0.08 | -- | -- |
11/13/2024 | Q3 | -- | $205K | -$0.09 | -- | -- |
08/08/2024 | Q2 | -- | $44K | -$0.14 | -- | -- |
05/09/2024 | Q1 | -- | -$125K | -$0.15 | -- | -- |
03/26/2024 | Q4 | -- | -$1.9M | -$0.46 | -- | -- |
11/14/2023 | Q3 | -- | -- | -$1.24 | -- | -- |
08/14/2023 | Q2 | -- | -- | -$0.01 | -- | -- |
03/31/2023 | Q1 | -- | -- | $0.02 | -- | -- |
12/31/2022 | Q4 | -- | -- | $0.12 | -- | -- |
09/30/2022 | Q3 | -- | -- | -$0.37 | -- | -- |
08/15/2022 | Q2 | -- | -- | $0.01 | -- | -- |
05/12/2022 | Q1 | -- | -- | -$0.07 | -- | -- |
03/30/2022 | Q4 | -- | -- | $0.27 | -- | -- |
09/30/2021 | Q3 | -- | -- | $1.14 | -- | -- |
06/30/2021 | Q2 | -- | -- | $0.08 | -- | -- |
03/31/2021 | Q1 | -- | -- | $0.00 | -- | -- |
12/31/2020 | Q4 | -- | -- | $0.03 | -- | -- |
09/30/2020 | Q3 | -- | -- | -$0.01 | -- | -- |
06/30/2020 | Q2 | -- | -- | $0.03 | -- | -- |
03/31/2020 | Q1 | -- | -- | -$0.06 | -- | -- |
12/31/2019 | Q4 | -- | -- | $0.01 | -- | -- |
09/30/2019 | Q3 | -- | -- | -$0.00 | -- | -- |
06/30/2019 | Q2 | -- | -- | -$0.04 | -- | -- |
03/31/2019 | Q1 | -- | -- | -$0.03 | -- | -- |
12/31/2018 | Q4 | -- | -- | -$1.13 | -- | -- |
09/30/2018 | Q3 | -- | -- | $0.11 | -- | -- |
08/14/2018 | Q2 | -- | -- | $0.05 | -- | -- |
03/31/2018 | Q1 | -- | -- | -$0.04 | -- | -- |
03/13/2018 | Q4 | -- | -- | -$0.00 | -- | -- |
11/14/2017 | Q3 | -- | -- | -$3.97 | -- | -- |
08/14/2017 | Q2 | -- | -- | $0.19 | -- | -- |
03/31/2017 | Q1 | -- | -- | $0.22 | -- | -- |
03/13/2017 | Q4 | -- | -- | -$0.39 | -- | -- |
11/14/2016 | Q3 | -- | -- | $0.50 | -- | -- |
08/15/2016 | Q2 | -- | -- | $0.14 | -- | -- |
05/19/2016 | Q1 | -- | -- | $0.17 | $0.19 | -$0.02 |
03/17/2016 | Q4 | -- | -- | $0.06 | $0.24 | -$0.18 |
11/11/2015 | Q3 | -- | -- | $0.12 | -- | -- |
Oxbridge Re Holdings reported $692K worth of top line sales in its most recent quarter.
Oxbridge Re Holdings announced earnings per share of -$0.02 which represents a miss of analyst forecast a -$0.02 per share.
Oxbridge Re Holdings reported -- that represents -- per share over the last quarter.
Oxbridge Re Holdings's earnings are forecast to decrease from -$0.45 per share to $0.01 per share next year representing a decrease of -93.33%.
Oxbridge Re Holdings's next earnings date is August 8, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.